Novo Nordisk CEO Says Wegovy Pill Sales Rose 20% in US in Q3
The CEO said the curve has flattened, without specifying what the curve refers to.
Related stories
Novo Nordisk Rises as Q3 Wegovy Pill Sales, Profit Beat Forecasts
M impact | EQUITY | Nov 04, 2026, 08:38 AM UTC
NLC India Q2 Consolidated Revenue From Operations INR 47,323.5 Million
M impact | EQUITY | Nov 04, 2026, 08:25 AM UTC
NAB to raise variable home loan rates by 0.25% p.a.
L impact | EQUITY | Nov 04, 2026, 08:25 AM UTC
NLC India Q2 Consolidated Net Profit INR 13,806.7 Million
M impact | EQUITY | Nov 04, 2026, 08:25 AM UTC
HL D&I Halla Q3 Operating Profit Rises 18% to 30 Billion Won
M impact | EQUITY | Nov 04, 2026, 08:24 AM UTC
BMW Expands Debrecen Plant to Three Shifts
BMW is adding a third shift at its Debrecen plant to meet demand for electric vehicles.
M impact | EQUITY | Nov 04, 2026, 08:24 AM UTC